JANUMET 50 mg/1

Janumet 50 mg/1 combines sitagliptin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Janumet 50 mg/1 is typically used to improve glycemic control in adults with type 2 diabetes. It is often prescribed alongside diet and exercise to help manage blood sugar levels. This medication is not suitable for type 1 diabetes or diabetic ketoacidosis. Always consult a healthcare provider to determine if Janumet 50 mg/1 is appropriate for your condition.

Common effects of Janumet 50 mg/1 may include gastrointestinal discomfort, such as nausea, diarrhea, or abdominal pain. Some users might experience headache, dizziness, or fatigue. These effects vary and are not experienced by everyone. If any symptoms persist or worsen, consult a healthcare professional.

Janumet 50 mg/1 should be used with caution in individuals with kidney or liver issues. It is important to stay hydrated and monitor blood sugar levels regularly. Avoid alcohol while taking this medication, as it can increase the risk of lactic acidosis. Always follow the advice of a healthcare provider regarding the use of Janumet 50 mg/1.

Janumet 50 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided, as it can increase the risk of side effects.